Press Releases

Filters
June 15, 2017

Debiopharm International SA Announces Completion of Enrollment in Phase I/II Clinical Trial with Debio 1143 in SCCHN

Read more
June 1, 2017

Debiopharm International SA Announces Results from Phase I Dose-Escalation Study of Debio 1347/CH5183284

Read more
June 1, 2017

GenePOC announces FDA clearance for revogene™ instrument and its GBS LB test

Read more
May 24, 2017

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Read more
May 9, 2017

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Read more
March 23, 2017

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study

Read more
March 10, 2017

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case

Read more
March 7, 2017

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Read more
March 2, 2017

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Read more